CHeBA

Researchers have offered renewed insight into ‘Quantum dot’ research, revealing its promising application in Alzheimer’s disease diagnosis and therapy.

A research collaboration has retrospectively reviewed the effectiveness of Special Dementia Care Programmes for people with very severe dementia symptoms.

Latest research from UNSW Sydney’s Centre for Healthy Brain Ageing (CHeBA) has uncovered new insight into the underlying mechanisms of Alzheimer’s disease.

Internationally renowned experts acknowledge that a standard assessment for individuals presenting with cognitive difficulty is an international priority.

Professor Lynn Chenoweth has been awarded $536,000 as one of five World Class Research Project Grants by the Dementia Centre for Research Collaboration (DCRC).

Dementia prevention needs to be Australia’s next public health area of focus, according to a Perspective published today.

Researchers at CHeBA Dr Suraj Samtani and Dr Simone Reppermund have won the highly competitive Dementia Australia Research Foundation grants.

Researchers at the Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney have the need for clearer definitions of ‘happiness’, ‘life satisfaction’ and ‘positive affect’ in centenarians.

A dietary supplement may represent a novel strategy for the treatment and/or prevention of cognitive impairment and Alzheimer’s disease.

CHeBA researchers have pinpointed mechanisms to reduce loneliness and improve social participation and belonging for people with dementia.

CHeBA Co-Director, Professor Henry Brodaty, along with an international research, has been awarded $400,000 to strengthen professional collaboration in dementia caregiver education and research.

A six-year study of older Australians in CHeBA’s Sydney Memory and Ageing Study has uncovered an Australian-first association between the impact of hearing loss on cognitive abilities and increased risk for dementia.

Evidence suggest people with dementia are more likely to contract COVID-19 and to have severe disease outcomes from the virus, including increased risk of death.

Software developed by CHeBA researchers has enabled an investigation into the relationship between sex differences and cerebral small vessel disease.

The evidence for the harmful effects of alcohol on brain health is compelling, but now experts have pin-pointed three key time periods in life when the effects of alcohol are likely to be at their greatest.

Research shows cognitive decline may be increased with use of antihypertensive medications.

A six-year study of older Australians with type 2 diabetes has uncovered a link between metformin use, slower cognitive decline and lower dementia rates.

The proportion of people with dementia in rural and regional Australia is consistent with that of metropolitan areas. Access to diagnosis and support however is not.